
Psychemedics Corporation PMD
Quarterly report 2024-Q3
added 11-12-2024
Psychemedics Corporation Operating Cash Flow 2011-2026 | PMD
Annual Operating Cash Flow Psychemedics Corporation
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -1.48 M | 4.89 M | 414 K | -4.08 M | 4.31 M | 7.93 M | 9.15 M | 9.27 M | 4.58 M | - | - | 3.09 M | 3.94 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 9.27 M | -4.08 M | 3.82 M |
Quarterly Operating Cash Flow Psychemedics Corporation
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | -473 K | - | - | - | -225 K | - | 3 M | 662 K | 345 K | - | -151 K | 237 K | -413 K | - | -5.22 M | -3.73 M | -413 K | - | 3.36 M | 1.69 M | 368 K | - | 4.01 M | 3.6 M | 1.41 M | - | 7.12 M | 3.43 M | 4.4 M | - | 6.07 M | - | - | - | - | - | - | - | - | - | - | - | - | - | 609 K | - | 2.48 M | 1.45 M | 167 K | - | 781 K | 854 K | -90.3 K |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 7.12 M | -5.22 M | 1.26 M |
Operating Cash Flow of other stocks in the Diagnostics research industry
| Issuer | Operating Cash Flow | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Akumin
AKU
|
65.4 M | - | -17.87 % | $ 25.9 M | ||
|
Centogene N.V.
CNTG
|
-21.7 M | - | -6.23 % | $ 30.6 M | ||
|
Agilent Technologies
A
|
1.48 B | $ 114.72 | -0.78 % | $ 34.9 B | ||
|
Co-Diagnostics
CODX
|
-29.1 M | $ 1.6 | -3.03 % | $ 2.13 M | ||
|
Accelerate Diagnostics
AXDX
|
-48.7 M | - | -61.36 % | $ 2.46 M | ||
|
Chembio Diagnostics
CEMI
|
-12.7 M | - | 0.22 % | $ 16.8 M | ||
|
Aspira Women's Health
AWH
|
-7.03 M | - | -6.19 % | $ 10.5 M | ||
|
Biocept
BIOC
|
-13.3 M | - | -13.05 % | $ 7.29 M | ||
|
Castle Biosciences
CSTL
|
64.9 M | $ 24.63 | -1.4 % | $ 684 M | ||
|
Check-Cap Ltd.
CHEK
|
-8 M | - | - | $ 9.42 M | ||
|
Enzo Biochem
ENZ
|
-26.3 M | - | -8.98 % | $ 14.8 K | ||
|
CareDx, Inc
CDNA
|
42 M | $ 22.1 | 1.14 % | $ 1.18 B | ||
|
Precipio
PRPO
|
685 K | $ 31.07 | 1.19 % | $ 49.9 M | ||
|
Illumina
ILMN
|
837 M | $ 126.85 | -1.3 % | $ 20.2 B | ||
|
DermTech
DMTK
|
-77 M | - | -11.32 % | $ 2.94 M | ||
|
Exact Sciences Corporation
EXAS
|
491 M | - | - | $ 19.8 B | ||
|
Fulgent Genetics
FLGT
|
21.1 M | $ 15.24 | -2.31 % | $ 461 M | ||
|
HTG Molecular Diagnostics
HTGM
|
-18.4 M | - | -20.0 % | $ 1.06 M | ||
|
Global Cord Blood Corporation
CO
|
614 M | - | - | $ 399 M | ||
|
Lantheus Holdings
LNTH
|
390 M | $ 82.87 | -1.47 % | $ 5.59 B | ||
|
Genetic Technologies Limited
GENE
|
-5.66 M | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-524 M | - | 0.12 % | $ 80.1 M | ||
|
Charles River Laboratories International
CRL
|
738 M | $ 166.83 | -2.57 % | $ 8.27 B | ||
|
National Research Corporation
NRC
|
26.4 M | $ 16.9 | -1.23 % | $ 378 M | ||
|
Guardant Health
GH
|
-185 M | $ 82.93 | -6.29 % | $ 10.4 B | ||
|
Heska Corporation
HSKA
|
-21.8 M | - | - | $ 1.31 B | ||
|
Interpace Biosciences
IDXG
|
5.83 M | $ 1.93 | - | $ 8.54 M | ||
|
Personalis
PSNL
|
-45.2 M | $ 5.49 | -7.89 % | $ 325 M | ||
|
Senseonics Holdings
SENS
|
-59.1 M | $ 7.15 | -1.65 % | $ 298 M | ||
|
Medpace Holdings
MEDP
|
713 M | $ 416.82 | -1.08 % | $ 12 B | ||
|
QIAGEN N.V.
QGEN
|
654 M | - | - | $ 10.6 B | ||
|
Motus GI Holdings
MOTS
|
-11.2 M | - | -34.28 % | $ 263 K | ||
|
Biomerica
BMRA
|
-3.84 M | $ 2.15 | -1.38 % | $ 4.94 M | ||
|
ICON Public Limited Company
ICLR
|
1.29 B | $ 101.08 | -2.07 % | $ 8.34 B | ||
|
Laboratory Corporation of America Holdings
LH
|
1.64 B | $ 260.29 | -1.19 % | $ 21.7 B | ||
|
Thermo Fisher Scientific
TMO
|
7.82 B | $ 467.93 | -0.02 % | $ 176 B | ||
|
Trinity Biotech plc
TRIB
|
13.2 M | $ 0.62 | -4.08 % | $ 61.9 M | ||
|
Neogen Corporation
NEOG
|
58.2 M | $ 9.12 | -3.54 % | $ 1.98 B | ||
|
Celcuity
CELC
|
-153 M | $ 122.59 | -2.46 % | $ 5.73 B | ||
|
Twist Bioscience Corporation
TWST
|
-47.6 M | $ 59.49 | -2.48 % | $ 3.56 B | ||
|
NeoGenomics
NEO
|
5.23 M | $ 8.9 | 3.43 % | $ 1.14 B | ||
|
Myriad Genetics
MYGN
|
1.8 M | $ 4.83 | -0.1 % | $ 447 M | ||
|
Natera
NTRA
|
-432 M | $ 200.24 | -2.03 % | $ 19.7 B | ||
|
Quest Diagnostics Incorporated
DGX
|
1.89 B | $ 195.7 | -0.47 % | $ 21.7 B | ||
|
Invitae Corporation
NVTA
|
-493 M | - | - | $ 21.2 M | ||
|
OpGen
OPGN
|
-4.87 M | - | -16.95 % | $ 1.54 M |